The female breast malignant neoplasms mortality rate in Canada is projected to rise slightly in the forecast period through 2028. In 2023, the baseline from which forecasts are made indicated stability. The projected data shows a gradual increase: 5.39 thousand deaths in 2024, escalating to 5.46 thousand by 2028. This denotes a modest year-on-year elevation of approximately 0.37% annually. Over the forecast period, a cumulative average growth rate (CAGR) of about 0.39% is expected.
Future trends to monitor include advancements in early detection and treatment, which may reduce mortality rates. Watch for changes in healthcare policies, public awareness campaigns, and research funding that could influence these forecasts.
